Nature's Sunshine (NATR) Q2 EPS Up 400%
Nature's Sunshine Products (NASDAQ:NATR), a direct seller of nutritional supplements and wellness products, reported second quarter 2025 earnings on July 31, 2025. GAAP revenue and earnings per share (EPS) exceeded Wall Street expectations. Revenue (GAAP) was $114.8 million versus an analyst estimate of $112.25 million, while non-GAAP diluted EPS was $0.35. This strong finish was driven by solid performances in Asia and North America, a slight improvement in gross margins, and continued cost management. However, operating income (GAAP) declined due to higher operating expenses, partially counterbalancing top-line gains. Management raised its full-year 2025 financial outlook, signaling confidence in continued momentum.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q3 2024 earnings report.
Nature's Sunshine Products develops and sells a wide range of dietary supplements, herbal products, and personal care solutions. It distributes its products through a global network of independent consultants, utilizing a direct selling model rather than traditional retail channels. The company’s portfolio consists of more than 800 products designed to support various health needs, with a focus on strict quality control and ongoing innovation at its Hughes Center for Research and Innovation.
Source Fool.com
